Juno Therapeutics and AstraZeneca collaborate to test cancer treatments

April 24, 2015 8:46 PM

17 0

Juno Therapeutics and AstraZeneca have announced collaboration to test their own cancer treatments, combining new therapies, which assure to use the immune system to deal with tumors.

With this deal, both will co-fund a Phase I study combining one of Juno's so-called CAR-T therapies and pair it with antibody developed by MedImmune, which is AstraZeneca's biologics-focused subsidiary. The trial is planned to be started this year. It will concentrate on patients, who have non-Hodgk...

Read more

To category page